Physician profile
Virak Tan
NPI 1841373438
$711,024.19
in general payments reported to CMS, 2019-2025
13 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,678 · 2020: $82.53 · 2021: $192 · 2022: $705K · 2023: $1,772 · 2024: $275 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $1,261 · Food and Beverage: $1,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $1,260.97 |
| Food and Beverage | $1,156.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $706,005.63 | 2020-2025 | Motoband, Va-Lcp, Na |
| Wright Medical Technology, INC. | $3,527.70 | 2019 | |
| Axogen | $610.03 | 2019-2025 | Avance Nerve Graft |
| Zimmer Biomet Holdings, INC. | $276.20 | 2021-2025 | A.L.P.S., Quattro |
| Skeletal Dynamics INC | $240.83 | 2024 | Ijs, Geminus, Implate |
| Smith+Nephew, INC. | $107.98 | 2022-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Stryker Corporation | $104.25 | 2019-2022 | |
| Pavmed INC. | $62.17 | 2021 | |
| Integra Lifesciences Corporation | $35.54 | 2019 | |
| Medartis INC. | $22.79 | 2020 | |
| Bioventus LLC | $16.11 | 2020 | |
| Endo Pharmaceuticals INC. | $14.96 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$104,525.09 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Virak Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.